l General Information |
Product Name | Indobufen |
General description | Indobufen is a reversible platelet aggregation inhibitor. It inhibits the platelet cyclooxygenase enzyme and suppresses thromboxane synthesis. |
Synonym | Ibustrin, K 3920; 2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid |
Purity | ≥99.0%(HPLC) | CAS Number | 63610-08-2 |
Formula | C18H17NO3 | Molecular Weight | 295.33 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥35mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Indobufen has been used in trials studying the supportive care and prevention of Atrial Fibrillation. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
